Aratana Therapeutics Receives $40M Credit Facility
Summary
Aratana Therapeutics (NASDAQ: PETX), a Kansas City, Kansas-based pet therapeutics company, received a $40m credit facility.Backers included Square 1 Bank, a division of Pacific Western Bank, and Oxford Finance LLC.The financing refinanced a $15m loan facility, with the additional $25m to be used to support the company’s continued growth.Founder, President & CEO, Aratana Therapeutics focuses on the licensing, development and commercialization of biopharmaceutical products for companion animals.Its pipeline currently includes treatments for pain management, inappetence, allergies, cancer, viral diseases and other conditions.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected